MetaCap

Anika Therapeutics (ANIK) vs Neuronetics (STIM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Anika Therapeutics (ANIK) has outperformed Neuronetics (STIM) over the past year, gaining 33.9% versus a loss of 4.6%. Over five years, ANIK leads with a -66.6% price change compared with -69.7% for STIM. Anika Therapeutics is the larger company by market cap ($177.2 million vs $120.6 million), about 1.5 times the size, while Neuronetics is growing revenue faster (+99.2% vs -5.9%).

Anika Therapeutics converts more of its revenue into profit, with a net margin of -9.6% versus -26.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ANIK+33.91%STIM-4.58%
+160%+71%-18%
Nov 21, 20251 yearNov 20, 2026
ANIK-66.98%STIM-68.75%
+79%-5%-90%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ANIK versus STIM key metrics
MetricANIKSTIM
Share price$13.23$1.25
Market cap$177.22M$120.60M
1-day change-0.38%+0.81%
YTD return+37.67%-9.42%
1-year return+33.91%-4.58%
5-year return-66.63%-69.66%
Forward P/E13.23—
EPS (TTM)$-0.03$-0.32
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$112.82M$149.16M
Revenue growth (YoY)-5.91%+99.17%
Net income (latest FY)$-10.88M$-39.00M
Gross margin56.56%48.48%
Operating margin-9.80%-21.08%
Net margin-9.64%-26.15%
52-week high$22.88$3.44
52-week low$9.01$0.80
Distance from 52-week high-42.18%-63.66%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+51.17%+380.00%
Average volume105.68K1.76M
Shares outstanding13.40M96.48M
Employees235658
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ANIK has outperformed STIM by 38.5 percentage points over the past year.
  • Anika Therapeutics is more profitable, keeping -9.6 cents of every revenue dollar as net income versus -26.1 cents for Neuronetics.
  • Neuronetics grew revenue faster in its latest fiscal year (+99.17% vs -5.91%).

About Anika Therapeutics

ANIK stock →

Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation.

Health Care · Medical/Dental Instruments · 235 employees

About Neuronetics

STIM stock →

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

Health Care · Medical/Dental Instruments · 658 employees

ANIK vs STIM FAQ

Which is bigger, Anika Therapeutics or Neuronetics?

Anika Therapeutics (ANIK) is larger, with a market capitalization of $177.22M compared with $120.60M for Neuronetics (STIM).

Which stock has performed better over the past year, ANIK or STIM?

ANIK returned +33.91% over the past 12 months, compared with -4.58% for STIM (price return, excluding dividends). Past performance does not predict future results.

Are Anika Therapeutics and Neuronetics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons